Study Summary
The main purpose of this study is to explore the therapeutic effect of CD20-targeted chimeric antigen receptor T(CAR-T) cells in the treatment of B cell malignancies.
Want to learn more about this trial?
Request More InfoInterventions
Anti-CD20-CAR-transduced T cellsBIOLOGICAL
Patients receive autologous-derived CD20-targeted CAR-T cells on day 1, 2 after receiving lymphodepleting chemotherapy.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Southwest Hospital of Third Millitary Medical University | Chongqing | Chongqing Municipality | China |